Processa Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Processa Pharmaceuticals, Inc. (PCSA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.31 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-03-20
- Processa Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $1.31M.
- Processa Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $1.31M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2023-12-31 | $1.31M 10-K · filed 2025-03-20 | |
| 2023-06-30 | $1.31M 10-Q · filed 2024-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |